John Romano, CEO, emphasized that "Tronox delivered a stronger finish to 2025 than anticipated by remaining focused on the things we can control and influence." He highlighted achieving the company's ...

The EC's decision to continue TiO2 use in drugs ensures stability and consistent supply, despite safety concerns in food applications. Alternatives to TiO2 exist but face challenges in matching its ...

Tronox (TROX) +4.9% in Monday's trading after the chemical manufacturing company issued preliminary Q4 revenues that beat estimates and said it plans to shut a titanium dioxide plant in China. Tronox ...